News blog | A.D.A.M Innovations

top of page

Services
Our science
About
CSR
Careers
News
More

Use tab to navigate through the menu items.

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

Oct 17

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform

Oct 2

Genesis Healthcare Becomes A.D.A.M. Innovations

Genesis Healthcare Becomes A.D.A.M. Innovations

Genesis Healthcare Becomes A.D.A.M. Innovations, Steering the Next Chapter of AI-Driven Genomics

Oct 1

Japan Society of Gene and Cell Therapy Conference

Japan Society of Gene and Cell Therapy Conference

Japan Society of Gene and Cell Therapy Conference

Jul 25

Co-Medical

Co-Medical

Co-Medical

Jul 24

Genesis Healthcare took part in AWS Genomics Community Day Tokyo

Genesis Healthcare took part in AWS Genomics Community Day Tokyo

Genesis Healthcare took part in AWS Genomics Community Day Tokyo

Jul 10

Covid PCR testing

Related sites

Phone number

+81-(0)3-5422-8506 (Japan)

Location

Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku,
Tokyo, 150-6026,
JAPAN

Compliance rules

© 2025 Genesis Healthcare Co. (to be renamed A.D.A.M. Innovations Co. effective Nov. 1, 2025). All rights reserved.

GeneLife, GeneLife WGS GenesisGaia and GeneLink are registered or pending registration trademarks of Genesis Healthcare Co. (to be renamed A.D.A.M. Innovations Co. effective Nov. 1, 2025)

bottom of page